logo

Exhibiting at VIV Asia 2025

3-5150
Bangkok
12 Mar - 14 Mar, 2025

Product Offerings

Products:

Aquatic Veterinary Medicine: CUSO4, Super Min, Sormeline, Glacan C, Flophenicol 50%

Veterinary Medicine: Powdered veterinary medicine, veterinary medicine in injection form, veterinary medicine solution

Thien Quan Joint Stock Company, headquartered in Can Tho City, Vietnam, is a leading manufacturer and distributor of veterinary and aquaculture pharmaceuticals. With over two decades of experience in the livestock and aquatic health sectors, Thien Quan has established itself as a reliable supplier of high-quality, scientifically formulated veterinary drugs serving the needs of Vietnam’s fast-growing livestock and aquaculture industries.

Company Overview

Founded in the Mekong Delta region—Vietnam’s aquaculture and agriculture heartland—Thien Quan JSC operates with a clear mission to improve animal health, enhance farm productivity, and contribute to the sustainable development of animal farming systems. The company produces a wide range of veterinary pharmaceuticals in compliance with national and international standards.

Core Business Areas

Thien Quan JSC focuses on the research, development, manufacturing, and commercialization of:

  • Aquatic veterinary pharmaceuticals
  • Livestock veterinary medicines
  • Preventive and therapeutic solutions
  • Custom formulations for farm use

Product Portfolio

Thien Quan manufactures and distributes hundreds of pharmaceutical formulations under various dosage forms:

Aquatic Veterinary Medicine

These products are designed for disease prevention, immune support, and environmental management in aquaculture systems, especially for shrimp and freshwater fish.

  • CUSO4 – Water treatment and anti-parasitic agent
  • Super Min – Mineral supplement enhancing shell formation in shrimp
  • Sormeline – Intestinal health and digestive enzyme support
  • Glacan C – Vitamin C complex with immune-stimulating properties
  • Flophenicol 50% – Antibacterial formulation for treating common infections

Veterinary Medicine (Livestock)

The company manufactures therapeutic and preventive products for poultry, pigs, and cattle in multiple dosage forms:

  • Powdered veterinary medicine – Oral administration antibiotics, antipyretics, and electrolyte/vitamin blends
  • Injectables – Targeted treatments for bacterial and viral infections
  • Solution forms – Water-soluble formulas for large-scale dosing

Thien Quan's product line covers common veterinary needs such as anti-diarrheal treatments, antibiotic combinations, multivitamins, and dewormers.

Manufacturing and Compliance

Thien Quan operates a GMP-certified production facility with the following capabilities:

  • Segregated zones for beta-lactam and non-beta-lactam production
  • Automated blending, filling, and packaging lines
  • In-house quality control and microbiology labs
  • High-speed granulation and sterile preparation systems

The facility is licensed by Vietnam’s Department of Animal Health under the Ministry of Agriculture and Rural Development and adheres to stringent national standards on pharmaceutical manufacturing.

Market Presence

Thien Quan has a strong distribution footprint across:

  • Vietnam – With a network of agents and dealers covering all 63 provinces, the company supplies products to shrimp farms, fish cooperatives, and animal husbandry businesses.
  • Export Markets – The company is actively expanding into Southeast Asian countries including Cambodia, Laos, and Myanmar. Its products have also reached select markets in the Middle East and Africa through agency-based distribution.

In 2022, it was estimated that Thien Quan served over 3,000 aquaculture farms and 1,200 livestock farms within Vietnam, making it one of the most regionally influential veterinary medicine providers in the Mekong Delta.

R&D and Innovation

Thien Quan maintains an internal research team responsible for:

  • Developing new formulations to address emerging aquatic diseases
  • Optimizing bioavailability and stability of veterinary actives
  • Enhancing resistance management strategies through rotational drug plans

Recent innovations include the integration of herbal and natural extracts into formulations to meet the growing demand for antibiotic-free and residue-compliant solutions, especially for shrimp intended for export markets such as the EU and Japan.

Sustainability and Regulatory Compliance

To align with global aquaculture sustainability goals, Thien Quan emphasizes:

  • Manufacturing products that meet zero-antibiotic residue standards
  • Promoting biosecurity and water quality management on farms
  • Advising farmers on the responsible use of antibiotics and probiotics

The company offers technical documentation and support to farmers seeking certifications like ASC, BAP, and GlobalG.A.P.

Strategic Advantages

  • Location Proximity: Being situated in Can Tho, the center of the Mekong Delta aquaculture zone, allows fast logistics and regional market knowledge.
  • Product Diversity: Offers one of the widest product portfolios in aquatic medicine in Vietnam.
  • GMP Manufacturing: Meets regulatory standards for both domestic and international sales.
  • Technical Support: Offers on-farm diagnosis, product usage training, and disease management consultation.

Future Outlook

Thien Quan JSC aims to:

  • Expand R&D into functional feed additives and nutraceuticals
  • Enter larger ASEAN and Middle Eastern markets through partnerships
  • Digitize supply chain and distribution systems
  • Collaborate with universities for clinical trials and product efficacy validation

With an integrated approach to animal health, regulatory compliance, and farmer education, Thien Quan Joint Stock Company is poised to remain a cornerstone of veterinary and aquaculture pharmaceutical innovation in Vietnam and the broader region.